Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11,250 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Breast cancer - one term, many entities?
Bertos NR, Park M. Bertos NR, et al. J Clin Invest. 2011 Oct;121(10):3789-96. doi: 10.1172/JCI57100. Epub 2011 Oct 3. J Clin Invest. 2011. PMID: 21965335 Free PMC article. Review.
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors.
Finak G, Sadekova S, Pepin F, Hallett M, Meterissian S, Halwani F, Khetani K, Souleimanova M, Zabolotny B, Omeroglu A, Park M. Finak G, et al. Breast Cancer Res. 2006;8(5):R58. doi: 10.1186/bcr1608. Breast Cancer Res. 2006. PMID: 17054791 Free PMC article.
Stromal gene expression predicts clinical outcome in breast cancer.
Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M. Finak G, et al. Nat Med. 2008 May;14(5):518-27. doi: 10.1038/nm1764. Epub 2008 Apr 27. Nat Med. 2008. PMID: 18438415
[The tumor microenvironment: a new tool to predict breast cancer outcome].
Finak G, Laferrière J, Hallett M, Park M. Finak G, et al. Med Sci (Paris). 2009 May;25(5):439-41. doi: 10.1051/medsci/2009255439. Med Sci (Paris). 2009. PMID: 19480818 French. No abstract available.
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.
Ponzo MG, Lesurf R, Petkiewicz S, O'Malley FP, Pinnaduwage D, Andrulis IL, Bull SB, Chughtai N, Zuo D, Souleimanova M, Germain D, Omeroglu A, Cardiff RD, Hallett M, Park M. Ponzo MG, et al. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12903-8. doi: 10.1073/pnas.0810402106. Epub 2009 Jul 17. Proc Natl Acad Sci U S A. 2009. PMID: 19617568 Free PMC article.
Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V. Deblois G, et al. Cancer Res. 2009 Aug 1;69(15):6149-57. doi: 10.1158/0008-5472.CAN-09-1251. Epub 2009 Jul 21. Cancer Res. 2009. PMID: 19622763
Crosstalk in Met receptor oncogenesis.
Lai AZ, Abella JV, Park M. Lai AZ, et al. Trends Cell Biol. 2009 Oct;19(10):542-51. doi: 10.1016/j.tcb.2009.07.002. Epub 2009 Sep 14. Trends Cell Biol. 2009. PMID: 19758803 Review.
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.
Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M, Gaboury L, Siegel PM. Rose AA, et al. Clin Cancer Res. 2010 Apr 1;16(7):2147-56. doi: 10.1158/1078-0432.CCR-09-1611. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215530
The Met receptor tyrosine kinase and basal breast cancer.
Ponzo MG, Park M. Ponzo MG, et al. Cell Cycle. 2010 Mar 15;9(6):1043-50. doi: 10.4161/cc.9.6.11033. Epub 2010 Mar 15. Cell Cycle. 2010. PMID: 20237428 Review.
11,250 results
Jump to page
Feedback